Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01475643 · ClinicalTrials.gov registry record · Phase 3
Loteprednol vs Prednisolone for the Treatment of Intraocular Inflammation Following Cataract Surgery in Children.
A Phase 3 study, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- Phase 3
- Development phase
- 107
- Enrollment target
NCT01475643 is a Phase 3 study that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 107 participants.
The verdict
NCT01475643, a Phase 3 study, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 107 participants
- Enrollment target
Study Summary
The objective of this study is to compare the efficacy and safety for the treatment of postoperative inflammation following ocular surgery for childhood cataract.
Interventions
- DRUG Loteprednol etabonate
- DRUG Prednisolones acetate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2013-06 |
| Est. Completion | 2017-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01475643
The ClinicalTrials.gov registry entry for NCT01475643 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 107 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch & Lomb Incorporated, which has 174 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Loteprednol etabonate is the first listed.
NCT01475643 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01475643 about?
NCT01475643 is a clinical study titled "Loteprednol vs Prednisolone for the Treatment of Intraocular Inflammation Following Cataract Surgery in Children.". The objective of this study is to compare the efficacy and safety for the treatment of postoperative inflammation following ocular surgery for childhood cataract.
What is the current status of trial NCT01475643?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 107 participants. The study started on 2013-06. Estimated completion is 2017-07.
What interventions are being tested in trial NCT01475643?
The interventions under investigation include: Loteprednol etabonate (DRUG), Prednisolones acetate (DRUG).
Who is sponsoring clinical trial NCT01475643?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.